Technetium Tc-99m Albumin Aggregated · Draximage Maa, Pulmotech Maa

What is Technetium Tc-99m Albumin Aggregated?

Technetium Tc-99m albumin aggregated is a radiopharmaceutical consisting of human serum albumin macroaggregates labeled with the gamma-emitting isotope technetium-99m. It is used for diagnostic imaging to evaluate pulmonary perfusion and peritoneovenous shunt patency, and is studied in hepatocellular carcinoma.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as

Draximage Maa, Pulmotech Maa, TC99M-MP 4006, 99mTc-Macro Albumin Aggregate

Drug type

Radiopharmaceutical

Therapy area

Oncology

Developer

Cis Bio Intl

In trials of

DRUG

FDA status

Approved as Draximage Maa, Pulmotech Maa (March 20, 2020), BLA210089 · FDA label

UNII

Z8E46IA45W

✅ FDA-approved uses

• Lung scintigraphy as an adjunct in the evaluation of pulmonary perfusion (Pulmotech Maa)
• Peritoneovenous shunt scintigraphy as an aid in the evaluation of its patency (Pulmotech Maa)
• Lung scintigraphy as an adjunct in the evaluation of pulmonary perfusion (Draximage Maa)
• Peritoneovenous shunt scintigraphy as an aid in the evaluation of its patency (Draximage Maa)

From the indications section of the FDA label (version of Oct 13, 2025). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

CarcinomaCarcinoma, HepatocellularLiver Neoplasm

Sources

• FDA Purple Book
• FDA label (DailyMed)
• FDA label Pulmotech Maa (2025-10-13), indications
• FDA label Draximage Maa (2024-02-13), indications
• NCI Thesaurus
• ClinicalTrials.gov NCT05848947

Updated Oct 3, 2026.